131 related articles for article (PubMed ID: 10205641)
1. Stability studies of a somatostatin analogue in biodegradable implants.
Rothen-Weinhold A; Besseghir K; Vuaridel E; Sublet E; Oudry N; Gurny R
Int J Pharm; 1999 Feb; 178(2):213-21. PubMed ID: 10205641
[TBL] [Abstract][Full Text] [Related]
2. Formation of peptide impurities in polyester matrices during implant manufacturing.
Rothen-Weinhold A; Oudry N; Schwach-Abdellaoui K; Frutiger-Hughes S; Hughes GJ; Jeannerat D; Burger U; Besseghir K; Gurny R
Eur J Pharm Biopharm; 2000 May; 49(3):253-7. PubMed ID: 10799817
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue.
Rothen-Weinhold A; Besseghir K; De Zelicourt Y; Gurny R
J Control Release; 1998 Mar; 52(1-2):205-13. PubMed ID: 9685950
[TBL] [Abstract][Full Text] [Related]
4. Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants.
Rothen-Weinhold A; Besseghir K; Vuaridel E; Sublet E; Oudry N; Kubel F; Gurny R
Eur J Pharm Biopharm; 1999 Sep; 48(2):113-21. PubMed ID: 10469929
[TBL] [Abstract][Full Text] [Related]
5. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.
Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B
J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900
[TBL] [Abstract][Full Text] [Related]
6. Manufacturing techniques of biodegradable implants intended for intraocular application.
Fialho SL; da Silva Cunha A
Drug Deliv; 2005; 12(2):109-16. PubMed ID: 15824036
[TBL] [Abstract][Full Text] [Related]
7. PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study.
Li D; Guo G; Fan R; Liang J; Deng X; Luo F; Qian Z
Int J Pharm; 2013 Jan; 441(1-2):365-72. PubMed ID: 23178216
[TBL] [Abstract][Full Text] [Related]
8. Recent Advance in Polymer Based Microspheric Systems for Controlled Protein and Peptide Delivery.
Yang Y; Chen Q; Lin J; Cai Z; Liao G; Wang K; Bai L; Zhao P; Yu Z
Curr Med Chem; 2019; 26(13):2285-2296. PubMed ID: 30963961
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of Octastatin, a somatostatin analogue: comparative accelerated stability studies of two formulations for freeze-dried products.
Barthomeuf C; Pourrat H; Pourrat A; Ibrahim H; Cottier PE
Pharm Acta Helv; 1996 Jul; 71(2):161-6. PubMed ID: 8810582
[TBL] [Abstract][Full Text] [Related]
10. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of Octastatin, a somatostatin analogue. Preparation of freeze-dried products for parenteral injection.
Pourrat H; Barthomeuf C; Pourrat A; Cottier PE; Ibrahim H
Biol Pharm Bull; 1995 May; 18(5):766-71. PubMed ID: 7492997
[TBL] [Abstract][Full Text] [Related]
12. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein.
Mi FL; Shyu SS; Lin YM; Wu YB; Peng CK; Tsai YH
Biomaterials; 2003 Dec; 24(27):5023-36. PubMed ID: 14559016
[TBL] [Abstract][Full Text] [Related]
13. Implant-associated local drug delivery systems based on biodegradable polymers: customized designs for different medical applications.
Sternberg K; Petersen S; Grabow N; Senz V; Meyer zu Schwabedissen H; Kroemer HK; Schmitz KP
Biomed Tech (Berl); 2013 Oct; 58(5):417-27. PubMed ID: 23979120
[TBL] [Abstract][Full Text] [Related]
14. Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants.
Prabhu S; Tran LP; Betageri GV
Drug Deliv; 2005; 12(6):393-8. PubMed ID: 16253955
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the delivery of peptide drugs: an industry perspective.
Lewis AL; Richard J
Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery.
Mathur V; Mudnaik R; Barde L; Roy A; Shivhare U; Bhusari K
Acta Pharm; 2010 Mar; 60(1):111-7. PubMed ID: 20228045
[TBL] [Abstract][Full Text] [Related]
18. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
[TBL] [Abstract][Full Text] [Related]
19. Sterilisation of bioresorbable polymer implants.
Bernkopf M
Med Device Technol; 2007; 18(3):26, 28-9. PubMed ID: 17585717
[TBL] [Abstract][Full Text] [Related]
20. Manufacturing techniques and excipients used during the design of biodegradable polymer-based microspheres containing therapeutic peptide/protein for parenteral controlled drug delivery.
Tamilvanan S; Venkatesh Babu R; Kannan K; Basu SK; Sa B
PDA J Pharm Sci Technol; 2008; 62(2):125-54. PubMed ID: 18540538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
